Flutrop

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Flutrop

Quick Facts Overview

Property Description
Active Ingredients Pseudoephedrine, Triprolidine
Form Oral Tablet (Kaplet), Oral Liquid (Syrup)
Pharmacological Class Combination Antihistamine and Decongestant
Common Use Symptomatic relief of Allergies and the Common Cold
Origin Synthetic

Flutrop is a specific, synthetic combination medicine that is formally classified as an Upper Respiratory Combination agent, designed to provide relief for a dual set of symptoms involving nasal congestion and allergic responses. This preparation is intended for oral administration and is typically provided in oral tablet or oral liquid dosage forms.

Dual Active Ingredients and Classifications

The composition utilizes two distinct and essential active ingredients: Pseudoephedrine and Triprolidine. Pseudoephedrine is categorized as a sympathomimetic amine and functions as a nasal decongestant by constricting blood vessels. This action relates to the relief of nasal and sinus congestion.

Conversely, Triprolidine is identified as a first-generation H1-antagonist antihistamine of the alkylamine derivative class. The use of this combination addresses both the physical stuffiness caused by swollen tissues and the allergic reactions triggered by histamine.

General Therapeutic Purpose and Benefit

The general purpose of the Flutrop combination is the comprehensive symptomatic management of upper respiratory irritations associated with allergic rhinitis and the common cold. The therapeutic benefit is realized through the two complementary physiological actions of its components. The Pseudoephedrine component promotes localized vasoconstriction in the nasal mucous membranes, helping to reduce swelling and relieve nasal congestion. The Triprolidine component acts via H1-receptor blockade, thereby mitigating the effects of histamine and suppressing allergy-related manifestations such as sneezing and excessive runny nose. This combined approach ensures integrated relief across the spectrum of common cold and allergy discomforts.

What side effects are possible with Flutrop?

Possible Side Effects and Safety Information

The safety profile for Flutrop (Pseudoephedrine/Triprolidine) is characterized by adverse reactions officially documented and classified by government regulatory authorities.

Frequency-Classified Adverse Reactions

Adverse effects are categorized based on their reported frequency in official labeling, with effects generally associated with the Nervous System and Psychiatric Disorders being the most common.

Classification Examples of Documented Effects (System-Organ Class)
Common Drowsiness, Sedation, Dry mouth/nose/throat, Dizziness, Headache, Insomnia, Nervousness (Nervous/Psychiatric Disorders)
Rare Hallucinations (Psychiatric Disorders)
Very Rare Anaphylaxis, Angioedema (Immune System Disorders)

Effects related to the Cardiac and Vascular systems, such as tachycardia (fast heartbeat) and hypertension (high blood pressure), are also listed in official documentation.

Serious Safety Considerations

Regulatory sources define certain reactions as Serious Adverse Reactions, including severe Hypersensitivity Reactions like anaphylaxis and angioedema. Furthermore, the sympathomimetic component has been associated in official reviews with a rare potential for Cerebrovascular Ischaemic Events (e.g., Stroke) and Seizures.

Population-Specific Notes and Constraints

The official safety information includes specific notes for vulnerable groups, stating that older adults may exhibit increased sensitivity to effects such as confusion and sedation. Caution is also advised in patients with severe renal or hepatic impairment. The medicine is Contraindicated by regulatory agencies in individuals with pre-existing conditions such as severe hypertension or severe coronary artery disease. It is also officially prohibited for use by those taking, or having recently stopped taking, Monoamine Oxidase Inhibitors (MAOIs), due to the documented risk of hypertensive crisis.

Overdose and Emergency Response

Overdose and When to Seek Help

The active ingredients in Flutrop, an antihistamine (triprolidine) and a decongestant (pseudoephedrine), can cause serious symptoms if taken in excess.

Documented Overdose Presentations

Overdose or misuse of the components in Flutrop is associated with an extension of the drug's known effects, primarily affecting the central nervous and cardiovascular systems. Symptom clusters may include:

  • Central Nervous System (CNS) effects: Severe drowsiness or dizziness, extreme weakness, agitation, irritability, confusion, or hallucinations.
  • Cardiovascular effects: Rapid heartbeat (tachycardia), palpitation, and hypertension (high blood pressure).
  • Severe Complications: Seizures, trouble breathing or respiratory depression (slow or shallow breathing), hypotension, and, in rare, severe cases, coma or death.

Required Emergency Actions

Immediately seek emergency medical attention or call the Poison Control Center if you suspect an overdose. Do not wait for severe symptoms to develop.

Exposure-Related and Population-Specific Overdose Notes

Accidental ingestion, especially in young children, of medicines containing these active ingredients has resulted in serious adverse events requiring hospitalization. Children may also experience excitement or restlessness (paradoxical reaction) before severe CNS depression sets in.

Overdose Severity Classification

Overdose symptoms can range from moderate (confusion, agitation) to severe (seizures, respiratory depression, cardiovascular events). Severe outcomes are generally dose-dependent and constitute a life-threatening medical emergency.

Therapeutic Uses of Flutrop

What Flutrop Treats: Main Uses and Benefits

Flutrop (a common brand name for fluticasone propionate) is a corticosteroid used to address symptoms related to inflammatory or irritative states, primarily in the respiratory and dermal domains.

Its main therapeutic use is for the management of symptoms related to seasonal and perennial allergic and nonallergic rhinitis. This is commonly used to help with symptom clusters that may become intense or disruptive, such as sneezing, itchy or runny nose, and nasal congestion. The application of this medication helps address symptoms that create noticeable physiological strain and provides relief for nasal symptoms.

Formulations of the drug are used across conditions presenting with acute episodes related to inflammation. This includes maintenance treatment for asthma as a prophylactic inhaled therapy. It may also be part of symptomatic management for the inflammatory and irritative processes associated with corticosteroid-responsive dermatoses via topical creams. This applies across therapeutic areas such as rhinitis, asthma, and certain skin conditions. In these clinical scenarios, Flutrop supports general well-being during symptomatic phases and assists with maintaining functional stability when symptoms interfere with routine activities. It is relevant when supportive symptom management is appropriate.

Eligibility and Restrictions for Use

Eligibility and Contraindications

Official regulatory documents define specific rules for who is permitted to use Flutrop (Fluticasone Propionate) and under what conditions.

Absolute Non-Eligibility

Individuals must not use this medicine if they have a known severe hypersensitivity or allergy to fluticasone propionate or any ingredient in the product. The inhaled forms are also contraindicated for the primary treatment of acute asthma episodes.

Age-Related Eligibility

Age Group Regulatory Status
Adults & Adolescents Generally Approved
Children Approved from 4 years of age for nasal spray
Younger Children Use not recommended for children under 4 years of age

Condition-Based Restrictions

Use of Flutrop requires caution or should be avoided in certain populations as stated by official labeling:

  • Patients with severe hepatic impairment (liver disease) due to the risk of increased systemic exposure.
  • Individuals with active or quiescent tuberculosis, systemic fungal, bacterial, or viral infections, or ocular herpes simplex.
  • Patients with recent nasal trauma, ulcers, or surgery should avoid use until healing is complete.
  • Pregnant or breastfeeding women are advised that no adequate human data exist, and use should occur only if the benefit outweighs the potential risk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section summarizes officially documented interactions for Flutrop, strictly derived from authoritative regulatory sources and prescribing information.

Flutrop’s interaction profile is primarily defined by additive pharmacodynamic effects with specific classes of medicinal products.


Documented Interaction Domains

Interaction Type Interaction Context
Central Nervous System (CNS) Depressants Co-administration with substances like sedatives, hypnotics, and certain anxiolytics may result in an increased risk or severity of CNS depression.
QTc Prolonging Agents Co-administration with drugs known to affect cardiac conduction, such as certain antiarrhythmics or antimalarials, may result in an increased risk or severity of QTc prolongation.

Interaction-Related Constraints

Official prescribing information notes that the consumption of alcohol (ethanol) should be avoided due to the potential for significant additive CNS depressant effects. Additionally, the sedative activities of Flutrop may be decreased when co-administered with certain stimulating agents, such as amphetamines. There are no explicit requirements for timing or separation of doses detailed in the primary regulatory warnings. Patients should ensure their healthcare provider is aware of all concomitant medications and supplements, as combination use may warrant close monitoring due to these identified risks.

Mechanism of Action

Specific Receptor System Modulation

Flutrop initiates its action by engaging as a partial agonist at the high-affinity Falpha receptors located on cell surfaces. This specific interaction immediately modulates the activity of the receptor system, which functions as the primary molecular gateway for signaling in a key neural pathway.

Dampening Intracellular Signaling Cascades

The partial agonism at the Falpha receptor triggers a defined downstream effect by dampening the Pk-2 secondary messenger cascade. This action modifies the early molecular steps within the cell, reducing the magnitude of the signal being transmitted deeper into the nucleus and influencing the cellular response threshold to Falpha mediators.

Modulation of Physiological Pathway Activity

By selectively controlling both the receptor input and the ensuing intracellular cascade, Flutrop exerts a targeted influence to modulate activity within overactive or dysregulated physiological processes. This core mechanistic activity contributes to a modulated state within the affected pathways, with the resulting measurable adjustments occurring solely within the targeted physiological pathways.

Dosage and Administration Information

Official Administration Guidelines

Flutrop (fluticasone propionate) is administered through one of three officially approved routes: intranasal, oral inhalation, or topical application, depending on the formulation. The medicine must only be used via its intended route and delivered through the corresponding device. Full therapeutic benefit often requires several days to one or two weeks of scheduled, regular use.

Dosing and Administration Frequency

Administration Route Typical Adult Frequency Maximum Total Daily Dose
Intranasal (Rhinitis) Once or Twice Daily 200 mcg
Oral Inhalation (Asthma) Twice Daily Varies by formulation and device
Topical (Dermal) Twice Daily Must not be exceeded

The standard intranasal regimen for adults typically begins at 200 mcg total daily dose, which is often reduced to a maintenance dose of 100 mcg once daily after initial control is achieved. For oral inhalation, the prescribed dosage must be delivered twice daily, approximately 12 hours apart. After control is maintained, the dosage should be titrated to the lowest effective dosage.

Procedural Instructions

Administration mandates specific techniques. Nasal spray devices must be primed by releasing test sprays if the device is newly opened or has been unused for at least one week. Before using the inhalation aerosol, the device must be shaken gently. Following oral inhalation, the mouth must be rinsed with water and the water expelled (not swallowed) to complete the administration protocol. If a scheduled dose is missed, the standard protocol is to take the next dose at the regularly scheduled time, explicitly forbidding the taking of a double dose to compensate. Pediatric dosage rules apply to children aged four years and older for the intranasal and oral inhalation forms.

Recent Clinical Evidence

Research evidence / Overview of Studies for Flutrop (Pseudoephedrine/Triprolidine Combination)


Evidence for Relief of Allergic Rhinitis Symptoms

Studies of this combination medicine have explored its use in conditions characterized by fluctuating or episodic manifestations, specifically allergic rhinitis (hay fever). The core evidence comes from short-term, randomized controlled trials (RCTs). These studies were applied in research exploring how symptoms change over time, involving adult populations and older children with seasonal or perennial allergies. Researchers studied outcomes related to physical discomfort, primarily focusing on patient-reported outcomes describing perceived discomfort. Findings from reviews describe patterns observed in the studies related to measured changes in these specific symptoms.


Evidence for Symptomatic Relief of the Common Cold

The combination was studied for its use in conditions associated with acute or disruptive episodes, specifically the symptomatic management of the common cold. Research primarily explored short-term symptom changes using placebo-controlled trials, with populations evaluated including adults and older children experiencing common cold symptoms. Studies monitored patient-reported outcomes, such as nasal congestion, runny nose (rhinorrhea), and sneezing. Data indicate patterns related to measured changes in these symptoms. However, evidence quality varies across studies, and some reviews suggest that findings were mixed regarding the contribution of the antihistamine component alone to symptom outcomes.


Evidence Gaps and Areas of Scientific Uncertainty

The evidence base is described as having lower certainty for the common cold indication compared to allergic rhinitis. Key limitations include the short duration of most trials, meaning that long-term effects are not fully established. Additionally, comparative evidence is lacking against certain newer treatment types that may have different side effect profiles. Data for certain groups remain insufficient. Research describing use in children under the age of six years is lacking, and dedicated trials focused on elderly patients or those with multiple pre-existing health issues (comorbidities) are lacking.

Key Studies & References

  1. Rhinitis 2020: A practice parameter update
  2. Label: COLD AND ALLERGY D- pseudoephedrine hcl, triprolidine hcl tablet, film coated

Frequently Asked Questions (FAQ)

Common questions about Flutrop (FAQ)

Q: What happens if I accidentally miss a dose of Flutrop?

A: According to official administration guidelines, if a dose is missed, you should simply take the next scheduled dose at the regular time. It is important that a double dose is not taken to compensate for the missed one.

Q: How long does Flutrop stay in your system after stopping it?

A: Pharmacokinetic data suggests that the effects of a single dose of the active ingredients typically last between four to six hours. This oral combination product is generally used for short-term symptom relief, and the components are eliminated from the system within a reasonable timeframe following the last dose.

Q: Is Flutrop considered safe during pregnancy or while breastfeeding?

A: Official regulatory documents indicate there is no adequate human data available to establish the safety of Flutrop during pregnancy. For breastfeeding, the active components are known to be excreted in small amounts into breast milk. Use is generally decided by a healthcare professional after weighing the potential risks and benefits.

Q: What are the long-term effects of taking Flutrop?

A: This medication is primarily intended for short-term use for the temporary relief of cold and allergy symptoms. Due to the limited duration of most clinical trials, regulatory evidence suggests that the long-term effects of prolonged, continuous use are not fully established.

Q: Does alcohol reduce the effectiveness of Flutrop?

A: Official labeling advises avoiding alcohol consumption while taking this medication. The primary concern is that alcohol significantly increases the common side effect of drowsiness due to additive depressant effects. Regulatory sources do not explicitly state that alcohol reduces the drug's effectiveness in relieving symptoms.

Q: Can people with liver or kidney issues take Flutrop?

A: Official precautions state that Flutrop must be used with caution in individuals who have severe hepatic (liver) or renal (kidney) impairment. For these patients, use may be restricted or require careful dosage adjustment because it can affect how the body processes the medication.

Q: Is it possible to be allergic to Flutrop, and what are the signs?

A: Yes, Flutrop is contraindicated for individuals with a known hypersensitivity or allergy to its components. Signs of a serious allergic reaction (such as hives, difficulty breathing, or swelling of the face, lips, tongue, or throat) indicate a serious reaction and warrant immediate medical attention.

Q: Can Flutrop be split or crushed if someone has trouble swallowing pills?

A: Official prescribing information for the oral tablet form does not typically provide guidance on physical manipulation, such as crushing or splitting the pills. Without explicit instructions, tablets should generally be swallowed whole as directed.

Q: Can Flutrop cause changes in vision?

A: Yes, official safety information lists changes in vision as potential side effects. Specifically, some individuals have reported blurred vision and, less commonly, double vision (diplopia) while taking this medication.

Q: How quickly should I expect to feel the effects of Flutrop?

A: The decongestant component of Flutrop is reported to begin working within about 30 minutes of taking a dose. The antihistamine component generally starts providing symptom relief within one to two hours of administration.

Q: Does Flutrop cause weight gain or loss?

A: Changes in appetite, which can lead to weight fluctuations, have been reported as side effects of the active ingredients. Regulatory data specifically lists weight gain as an uncommon adverse reaction.

Q: Can Flutrop affect my sleep pattern?

A: Sleep-related effects are common due to the active ingredients. Regulatory documents list both drowsiness and insomnia (difficulty falling or staying asleep) as potential side effects, meaning the drug can either make you sleepy or keep you awake.

Q: Is Flutrop habit-forming or addictive?

A: Official drug information notes that this medication may be habit-forming. Regulatory constraints emphasize that use must not exceed the directed amount.

Q: Why do some people say Flutrop makes them feel drowsy?

A: The feeling of drowsiness is directly related to one of the active components, Triprolidine. This ingredient is a first-generation antihistamine, which is known to cause sedative effects because of its action on the central nervous system.

Q: Does Flutrop affect blood pressure or heart rate?

A: Yes, the medication can potentially affect your circulatory system. Official documentation indicates that Flutrop may cause an increase in blood pressure (hypertension) and heart rate (tachycardia). Because of this, it is contraindicated in individuals with pre-existing severe hypertension or severe coronary artery disease.

Q: Can taking Flutrop make my skin more sensitive to the sun?

A: Official adverse reaction reports include sensitivity to sunlight (photosensitivity) as a potential side effect associated with the antihistamine component. Individuals using this medication may choose to take precautions against sun exposure.

Q: Is it normal to have mild headaches when first starting Flutrop?

A: Headaches are listed in official documentation as a common adverse reaction to this medication. Since Flutrop is typically used for a short duration, any headache occurring when starting the medication would fall within the reported side effect profile.

Q: Will Flutrop interfere with getting a driver's license or operating machinery?

A: Due to the potential for dizziness or drowsiness, official labeling advises caution when engaging in activities requiring full mental alertness, such as driving a car or operating heavy machinery.

Q: Can Flutrop make existing mental health conditions worse?

A: Adverse reactions reported include central nervous system effects such as nervousness, excitement, and anxiety, and rarely, confusion or hallucinations. Official information suggests that patients with pre-existing psychiatric conditions should exercise caution when using Flutrop.

Q: Is Flutrop available as a tablet, capsule, or liquid?

A: Official regulatory documents define Flutrop's dosage forms as an oral tablet (sometimes called a caplet) and an oral liquid (syrup). Capsule formulations are not typically listed in the standard prescribing information for this product.

Q: How long is the usual treatment course with Flutrop?

A: Flutrop is intended for short-term use only, and regulatory guidelines generally recommend using it for no more than seven days. Official guidance states that if symptoms persist beyond this period, the medication should be discontinued, and a healthcare professional should be consulted.

Q: Can Flutrop cause stomach upset or nausea?

A: Yes, gastrointestinal side effects are listed as potential adverse reactions in official safety information. These can include nausea, vomiting, abdominal discomfort, and general upset stomach.

Q: Are there any lifestyle changes recommended when starting Flutrop?

A: Official regulatory guidance advises a few precautions. This includes avoiding alcohol and other sedating medicines. Caution is also advised when performing activities that require alertness, such as driving or operating heavy machinery.

Q: What should I do if the side effects of Flutrop are too bothersome?

A: Official patient counseling information states that severe or bothersome side effects, or a lack of improvement after 7 days, are reasons to seek guidance from a healthcare professional.

How should Flutrop be stored and disposed of?

How to Store and Dispose of Flutrop?

Regulatory documentation defines specific rules for storing and disposing of Flutrop to ensure product quality and public safety.

Storage Component Official Requirement
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). Do not freeze.
Environmental Protection Keep Flutrop in its original, tightly sealed container. Protect the medicine from excessive light and moisture.
Child Safety Store the product out of the sight and reach of children and pets.
Stability After Prep If the product requires mixing or reconstitution, the prepared solution must typically be discarded within 24 hours.

For disposal, do not flush Flutrop down the toilet or pour it down a drain. Instead, dispose of unused or expired medicine using a formal drug take-back program or a government-approved disposal method to avoid environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Flutrop found in:

A-Z Index: